
To describe the zzso and zzso changes after zzso zzso zzso and zzso growth factor zzso zzso in patients with zzso zzso zzso 

A total of 15 patients with zzso high-grade zzso were treated on a prospective Phase I trial combining zzso and zzso The zzso dose was escalated from 18 to 36 zzso in three zzso The planning target volume was the zzso zzso zzso zzso plus 2 zzso zzso was given at 250 zzso zzso zzso brain magnetic resonance imaging scans were analyzed to characterize the zzso changes in the zzso and zzso abnormalities after zzso Two patients underwent zzso for suspected zzso 

The median zzso magnetic resonance imaging zzso and zzso volume was zzso and zzso zzso zzso The median zzso percentage of increases in the zzso volume at 1, zzso and zzso months was zzso zzso and zzso zzso The median percentage increase in the zzso volume likewise showed a trend upward after zzso from zzso at 1 month to zzso at zzso zzso For the 2 patients who underwent zzso after zzso for an increasing zzso volume, the zzso analysis revealed zzso vascular injury and zzso One patient with an zzso increase in the zzso volume after zzso was treated zzso After a peak zzso volume increase at 9 months, the zzso volume had declined to 50% of the zzso volume at 15 zzso The patients with the most dramatic increase in zzso volume experienced the longest overall zzso 

Patients experienced a notable increase in magnetic resonance imaging zzso and zzso volumes after the combination of zzso and zzso growth factor zzso zzso The tissue changes were consistent with a potent treatment zzso 

